hero section gradient
15 handpicked stocks

IBM AMD Quantum Partnership: What's Next for Chips?

IBM's successful use of AMD's conventional chips for quantum computing has accelerated its development timeline, signaling a new investment opportunity in the semiconductor companies enabling this hybrid approach.

Author avatar

Han Tan | Market Analyst

Published on October 25

Your Basket's Financial Footprint

Market capitalisation breakdown and investor key points for the provided basket.

Key Takeaways for Investors:
  • Large-cap dominance suggests lower volatility and more predictable returns, often tracking broad market movements.
  • Suitable as a core holding for diversified portfolios, not a speculative, high-risk growth allocation.
  • Expect steady, long-term appreciation rather than rapid, short-term gains; growth will generally be gradual.
Total Market Cap
  • IBM: $268.75B

  • AMD: $373.63B

  • INTC: $175.96B

  • Other

About This Group of Stocks

1

Our Expert Thinking

IBM's breakthrough with AMD chips running quantum algorithms a year ahead of schedule validates a hybrid approach to quantum computing. This signals a shift towards integrating classical semiconductor technology with quantum systems, creating new demand for specialized hardware components across the semiconductor value chain.

2

What You Need to Know

This group focuses on companies that manufacture the critical hardware enabling hybrid quantum-classical systems. These include FPGA producers, high-performance processor makers, and specialized semiconductor foundries. The theme represents both established tech giants and emerging quantum-focused companies positioned for this technological evolution.

3

Why These Stocks

These companies were handpicked by professional analysts based on their strategic positioning in the quantum computing supply chain. From IBM's quantum leadership to AMD's breakthrough chips, and ASML's essential manufacturing equipment, each represents a key piece of the hybrid quantum computing puzzle.

Why You'll Want to Watch These Stocks

Breakthrough Momentum

IBM's quantum algorithms running on AMD chips a year ahead of schedule shows this technology is accelerating faster than expected. Early investors could benefit from this rapid progress.

🔗

Hybrid Revolution

The shift towards quantum-classical hybrid systems creates new demand for conventional semiconductors in quantum applications. This opens up massive market opportunities for established chip makers.

🎯

Strategic Positioning

These companies control critical parts of the quantum computing supply chain, from chip manufacturing to quantum systems. Their strategic positions could translate into significant returns as the market expands.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Railroad Investment: Beyond the $85 Billion Merger

Railroad Investment: Beyond the $85 Billion Merger

Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.

Oracle TikTok Deal May Boost Stocks in 2025

Oracle TikTok Deal May Boost Stocks in 2025

TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.

Pharma Reshoring Explained | Manufacturing Investment

Pharma Reshoring Explained | Manufacturing Investment

Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.

Frequently Asked Questions